March 03, 2015 10:17 AM ET

Biotechnology

Company Overview of Excaliard Pharmaceuticals, Inc.

Company Overview

Excaliard Pharmaceuticals, Inc., a biotechnology company, engages in the development and commercialization of drugs/therapeutics for the treatment of dermatological disorders. Its products include EXC 001, an antisense medicine for reducing fibrosis, the amelioration of skin scarring, and other fibrotic disorders/diseases. Excaliard Pharmaceuticals was founded in 2006 and is based in Carlsbad, California. As of November 30, 2011, Excaliard Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.

2141 Palomar Airport Road

Suite 300

Carlsbad, CA 92011

United States

Founded in 2006

Phone:

760-431-1850

Fax:

760-431-1385

Key Executives for Excaliard Pharmaceuticals, Inc.

Chief Executive Officer, President, and Director
Age: 60
Founder, Chief Scientific Officer and Director
Chief Financial Officer
Age: 51
Chief Medical Officer
Head of Regulatory Affairs and Project Management
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
DEKALB Genetics Corporation United States
Metheor Therapeutics Corporation United States
Vidus Ocular, Inc. United States
Carolus Therapeutics, Inc. United States
Liquidia Technologies, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Excaliard Pharmaceuticals, Inc., please visit excaliard.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.